Clinical Trial Update: Risperidone and Desipramine in Alcohol Use and Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial of risperidone and desipramine in patients with schizophrenia and alcohol use disorder has completed; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Schizophrenia

Drugs mentioned

• NORPRAMIN (Desipramine hydrochloride)
• Risperdal (risperidone)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Schizophrenia, Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2018-03-23